𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P1-367 Tolerability, safety and efficacy in patients with Alzheimer's disease who are switched from donepezil to galantamine

✍ Scribed by Alexander F. Kurz; Michael Gold

Book ID
117413240
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
286 KB
Volume
25
Category
Article
ISSN
0197-4580

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Tolerability of switching from donepezil
Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease
✍ Gunhild Waldemar; Maritta HyvΓ€rinen; Mette Krog Josiassen; Alex KΓΈrner; Heikki L πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 44 KB πŸ‘ 2 views

This study investigates the tolerability, safety and efficacy of abrupt or stepwise switching from donepezil to memantine treatment in patients with moderate-to-severe Alzheimer's disease (AD). Outpatients (Table 1), !50 years, with dementia of the Alzheimer's type (DSM-IV-TR), MMSE 18 and receiving

Efficacy and safety of donepezil in pati
Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial
✍ Howard Feldman; Serge Gauthier; Jane Hecker; Bruno Vellas; Yikang Xu; John R. Ie πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 634 KB

## Abstract ## Background There have been very limited investigations of cholinesterase inhibitor therapy in more advanced stages of Alzheimer's disease (AD). The efficacy and safety of donepezil were evaluated in __post hoc__ analyses of a subgroup of patients with more severe AD (standardized Mi